Search

What have we learned from the pandemic and how can we address the coming challenges?

University “The success of the mRNA vaccine technology for COVID-19, I believe, has huge implications for the cancer vaccine field and, ultimately, for combination vaccine and cell therapy approaches for

recent breakthrough discovery was the development of mRNA vaccines. The COVID-19 pandemic accelerated the validation of the use of mRNA in the form of vaccines for the treatment of infectious diseases, which

The pharmaceutical industry experienced its fair share of challenges and success in 2021. We break down the sector's biggest moments here.

GlaxoSmithKline’s Senior Vice President of US Oncology speaks about the pandemic and its impact on patients.

We ask medicine makers around the world to tell us how their professional and personal lives have changed over the course of the COVID-19 crisis.

How has the COVID-19 pandemic changed the industry? And how can we respond faster next time?

The UK approves Pfizer/BioNTech’s COVID-19 vaccine for emergency use.

It’s December – time for The Medicine Maker to welcome you to 2023’s most innovative new technologies in drug development and manufacturing

COVID-19 crisis has given researchers, financiers, and industrialists an extraordinary lesson. The mRNA vaccine represents, indeed, an extraordinary scientific and technological revolution. It is perhaps the